Frontiers in Immunology | Cytokines and Soluble Mediators in Immunity

Original Research

Published on 10 May 2024

The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice

in Cytokines and Soluble Mediators in Immunity

Wenkai Xia
Nuru Eltrich
Volker Vielhauer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377913

3,452 views
3 citations

Original Research

Published on 29 Apr 2024

Exploring causal correlations between inflammatory cytokines and Ménière’s disease: a Mendelian randomization

in Cytokines and Soluble Mediators in Immunity

SongTao Xie
RuoFeng Zhang
YuRou Tang
QingQing Dai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373723

5,471 views
11 citations

Original Research

Published on 26 Apr 2024

Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells

in Cytokines and Soluble Mediators in Immunity

Sabina Di Matteo
Maria Teresa Bilotta
Andrea Pelosi
Dorothee Haas
Tobias Theinert
Gerrit Weber
Paul-Gerhardt Schlegel
Matthias Berg
Lorenzo Moretta
Enrico Maggi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382931

5,166 views
4 citations

Review

Published on 26 Apr 2024

Chemokines and lymphocyte homing in Sjögren’s syndrome

in Cytokines and Soluble Mediators in Immunity

Jiahe Liao
Xinbo Yu
Ziwei Huang
Qian He
Jianying Yang
Yan Zhang
Jiaqi Chen
Weijiang Song
Jing Luo
Qingwen Tao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1345381

9,562 views
18 citations

Review

Published on 24 Apr 2024

The Immunomodulatory effect of exosomes in diabetes: a novel and attractive therapeutic tool in diabetes therapy

in Cytokines and Soluble Mediators in Immunity

Na Li
Lingli Hu
Jingyang Li
Yang Ye
Zhengyang Bao
Zhice Xu
Daozhen Chen
Jiaqi Tang
Ying Gu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1357378

6,200 views
7 citations

Original Research

Published on 22 Apr 2024

The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation

in Cytokines and Soluble Mediators in Immunity

Ylenia Longo
Sara Moreno Mascaraque
Giuseppe Andreacchio
Julia Werner
Ichiro Katahira
Elena De Marchi
Anna Pegoraro
Robert Jan Lebbink
Karl Köhrer
Patrick Petzsch

Frontiers in Immunology

doi 10.3389/fimmu.2024.1360140

4,624 views
5 citations

Original Research

Published on 15 Apr 2024

The glycosaminoglycan-binding chemokine fragment CXCL9(74–103) reduces inflammation and tissue damage in mouse models of coronavirus infection

in Cytokines and Soluble Mediators in Immunity

Vivian Louise Soares Oliveira
Celso Martins Queiroz-Junior
Delphine Hoorelbeke
Felipe Rocha da Silva Santos
Ian de Meira Chaves
Mauro Martins Teixeira
Remo de Castro Russo
Paul Proost
Vivian Vasconcelos Costa
Sofie Struyf

Frontiers in Immunology

doi 10.3389/fimmu.2024.1378591

5,721 views
5 citations

Review

Published on 15 Apr 2024

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

in Cytokines and Soluble Mediators in Immunity

James G. Krueger
Kilian Eyerich
Vijay K. Kuchroo
Christopher T. Ritchlin
Maria T. Abreu
M. Merle Elloso
Anne Fourie
Steven Fakharzadeh
Jonathan P. Sherlock
Ya-Wen Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1331217

43,070 views
76 citations

Original Research

Published on 12 Apr 2024

Inflammatory cytokine profiles in erectile dysfunction: a bidirectional Mendelian randomization

in Cytokines and Soluble Mediators in Immunity

Dongze Liu
Zheng Qin
Bocun Yi
Hongbo Xie
Yunan Liang
Liang Zhu
Kuo Yang
Hongtuan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1342658

3,927 views
10 citations

Original Research

Published on 10 Apr 2024

Interferon alpha promotes caspase-8 dependent ultraviolet light-mediated keratinocyte apoptosis via interferon regulatory factor 1

in Cytokines and Soluble Mediators in Immunity

Shannon N. Loftus
Mehrnaz Gharaee-Kermani
Bin Xu
Tyson M. Moore
Andrew Hannoudi
Mischa J. Mallbris
Benjamin Klein
Johann E. Gudjonsson
J. Michelle Kahlenberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384606

4,911 views
9 citations

Correction

Published on 08 Apr 2024

Corrigendum: Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE

in Cytokines and Soluble Mediators in Immunity

Christophe Wong
Ivana Stoilova
Florence Gazeau
Jean-Philippe Herbeuval
Thibaut Fourniols

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386412

1,517 views

Review

Published on 04 Apr 2024

Therapeutic potential of interleukin-21 in cancer

in Cytokines and Soluble Mediators in Immunity

Gheorghita Isvoranu
Marioara Chiritoiu-Butnaru

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369743

10,603 views
20 citations

Original Research

Published on 03 Apr 2024

Immune system-related plasma extracellular vesicles in healthy aging

in Cytokines and Soluble Mediators in Immunity

Xin Zhang
Sisi Ma
Janet L. Huebner
Syeda Iffat Naz
Noor Alnemer
Erik J. Soderblom
Constantin Aliferis
Virginia Byers Kraus

Frontiers in Immunology

doi 10.3389/fimmu.2024.1355380

6,088 views
3 citations

Hypothesis and Theory

Published on 02 Apr 2024

TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations

in Cytokines and Soluble Mediators in Immunity

Zeev Elkoshi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371753

6,361 views
14 citations

Original Research

Published on 20 Mar 2024

Alveolar cytokines and interferon autoantibodies in COVID-19 ARDS

in Cytokines and Soluble Mediators in Immunity

Trine B. Jonassen
Sofie E. Jørgensen
Nikki H. Mitchell
Trine H. Mogensen
Ronan M. G. Berg
Andreas Ronit
Ronni R. Plovsing

Frontiers in Immunology

doi 10.3389/fimmu.2024.1353012

2,623 views
1 citation

Review

Published on 14 Mar 2024

Mitochondrial extracellular vesicles, autoimmunity and myocarditis

in Cytokines and Soluble Mediators in Immunity

Damian N. Di Florio
Danielle J. Beetler
Elizabeth J. McCabe
Jon Sin
Tsuneya Ikezu
DeLisa Fairweather

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374796

8,074 views
13 citations

Editorial

Published on 14 Mar 2024

Editorial: Women in cytokines and soluble mediators in immunity

in Cytokines and Soluble Mediators in Immunity

Diana Boraschi
Giselle Penton-Rol
Olukemi Amodu
Marita Troye Blomberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395165

2,137 views

Original Research

Published on 12 Mar 2024

Early host immune responses in a human organoid-derived gallbladder monolayer to Salmonella Typhi strains from patients with acute and chronic infections: a comparative analysis

in Cytokines and Soluble Mediators in Immunity

Rosângela Salerno-Goncalves
Haiyan Chen
Andrea C. Bafford
Mariana Izquierdo
Juan Carlos Hormazábal
Rosanna Lagos
Hervé Tettelin
Adonis D’Mello
Jayaum S. Booth
Alessio Fasano

Frontiers in Immunology

doi 10.3389/fimmu.2024.1334762

3,785 views
4 citations

Original Research

Published on 11 Mar 2024

Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19

in Cytokines and Soluble Mediators in Immunity

Daisuke Kasugai
Taku Tanaka
Takako Suzuki
Yoshinori Ito
Kazuki Nishida
Masayuki Ozaki
Takeo Kutsuna
Toshiki Yokoyama
Hitoshi Kaneko
Ryo Ogata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1337070

3,197 views

Mini Review

Published on 08 Mar 2024

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation

in Cytokines and Soluble Mediators in Immunity

Marie Bielenberg
Roberta Kurelic
Stefan Frantz
Viacheslav O. Nikolaev

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365484

6,213 views
9 citations

Original Research

Published on 08 Mar 2024

Revisiting roles of mast cells and neural cells in keloid: exploring their connection to disease activity

in Cytokines and Soluble Mediators in Immunity

Eunhye Yeo
Joonho Shim
Se Jin Oh
YoungHwan Choi
Hyungrye Noh
Heeyeon Kim
Ji-Hye Park
Kyeong-Tae Lee
Seok-Hyung Kim
Dongyoun Lee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1339336

8,253 views
2 citations

Original Research

Published on 07 Mar 2024

Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro

in Cytokines and Soluble Mediators in Immunity

Hesham M. Shehata
Pranay Dogra
Sarah Gierke
Patrick Holder
Shomyseh Sanjabi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1341804

4,720 views
4 citations

Original Research

Published on 06 Mar 2024

Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection

in Cytokines and Soluble Mediators in Immunity

Weicong Ren
Zichun Ma
Qiang Li
Rongmei Liu
Liping Ma
Cong Yao
Yuanyuan Shang
Xuxia Zhang
Mengqiu Gao
Shanshan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1359555

4,322 views
5 citations

Editorial

Published on 05 Mar 2024

Editorial: Role of carcinoembryonic antigen-related cell adhesion molecules in pathogen responses, tumorigenicity, and immune modulation

in Cytokines and Soluble Mediators in Immunity

Vishal Khairnar
Vu N. Ngo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388453

2,117 views
1 citation

1,282 articles

articles

The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice

Exploring causal correlations between inflammatory cytokines and Ménière’s disease: a Mendelian randomization

Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells

Chemokines and lymphocyte homing in Sjögren’s syndrome

The Immunomodulatory effect of exosomes in diabetes: a novel and attractive therapeutic tool in diabetes therapy

The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation

The glycosaminoglycan-binding chemokine fragment CXCL9(74–103) reduces inflammation and tissue damage in mouse models of coronavirus infection

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

Inflammatory cytokine profiles in erectile dysfunction: a bidirectional Mendelian randomization

Interferon alpha promotes caspase-8 dependent ultraviolet light-mediated keratinocyte apoptosis via interferon regulatory factor 1

Corrigendum: Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE

Therapeutic potential of interleukin-21 in cancer

Immune system-related plasma extracellular vesicles in healthy aging

TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations

Alveolar cytokines and interferon autoantibodies in COVID-19 ARDS

Mitochondrial extracellular vesicles, autoimmunity and myocarditis

Editorial: Women in cytokines and soluble mediators in immunity

Early host immune responses in a human organoid-derived gallbladder monolayer to Salmonella Typhi strains from patients with acute and chronic infections: a comparative analysis

Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation

Revisiting roles of mast cells and neural cells in keloid: exploring their connection to disease activity

Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro

Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection

Editorial: Role of carcinoembryonic antigen-related cell adhesion molecules in pathogen responses, tumorigenicity, and immune modulation